Unitree Robotics & Morgan Stanley

Unitree Robotics: Unitree Robotics is a leading Chinese robotics company that shipped over 5,000 humanoid robots in 2025. It reported 1.7 billion yuan in revenue and over 278 million yuan in profit last year, indicating profitability.

Morgan Stanley: Morgan Stanley provides market estimates for the humanoid robot industry, forecasting significant growth in sales and a potential $5 trillion market.

Unitree Robotics: Unitree is the central entity, completing a record IPO and seeing its shares surge over 600% on debut. The listing provides significant capital for R&D and expansion, but faces risks from U.S. trade restrictions.

Morgan Stanley: Raised its forecast for China's humanoid robot shipments, indicating confidence in the industry's growth.

Unitree Robotics: Unitree Robotics received approval for a listing in Shanghai, serving as an early test for a broader wave of robotics IPOs in China. This event is crucial for its future funding and market position.

Morgan Stanley: Morgan Stanley analysts provided insights into the market interest in Chinese humanoids and the allocation of IPO funds towards R&D, offering expert commentary on the event.

Unitree Robotics: Unitree Robotics, a leading Chinese humanoid robot maker, is directly affected by the ban, which blocks new imports of its robots. The company may lose access to the US market, though it can pivot to other regions.

Morgan Stanley: Morgan Stanley forecast China's humanoid robot market at $15 billion by 2030, highlighting the industry's growth.

Unitree Robotics: Nvidia is expanding its partnership with Unitree Robotics, introducing a robotics design template, which could increase Unitree's visibility and market reach in the robotics component sector.

Morgan Stanley: Morgan Stanley provided estimates on the increasing cost share of memory in AI platforms, highlighting the growing financial significance of HBM.